Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score N/A
- Piotroski Score N/A
- Grade Buy
- Symbol (CRGX)
- Company CARGO Therapeutics, Inc. Common Stock
- Price $22.15
- Changes Percentage (0.68%)
- Change $0.15
- Day Low $22.09
- Day High $22.78
- Year High $33.92
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 12/11/2024
- Fiscal Year End N/A
- Average Stock Price Target $32.00
- High Stock Price Target $34.00
- Low Stock Price Target $28.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.00
- Trailing P/E Ratio N/A
- Forward P/E Ratio N/A
- P/E Growth N/A
- Net Income $-98,147,000
Income Statement
Quarterly
Annual
Latest News of CRGX
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
With 54% ownership of the shares, CARGO Therapeutics, Inc. (NASDAQ:CRGX) is heavily dominated by institutional owners
Ownership research, including analyst forecasts, aids in understanding stock opportunities. Institutional investors hold majority shares in CARGO Therapeutics, influencing market moves. Insider and pu...
By Yahoo! Finance | 1 month ago
